Hunan Hansen Pharmaceutical Co (SZSE:002412) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 25, 2025)

View and export this data going back to 2011. Start your Free Trial

What is Hunan Hansen Pharmaceutical Co Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Hunan Hansen Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Hunan Hansen Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Hansen Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hunan Hansen Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Hansen Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Hunan Hansen Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Hunan Hansen Pharmaceutical Co (SZSE:002412) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Hunan Hansen Pharmaceutical Co Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Hunan Hansen Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Hansen Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Hansen Pharmaceutical Co Ltd (SZSE:002412) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Traded in Other Exchanges

N/A

Address

Silver City Road, Long Ridge Industrial Park, Heshan District, Yiyang City, CHN, 413000

Website

http://www.hansenzy.com

Hunan Hansen Pharmaceutical Co Ltd is producing Chinese and Western medicines. Its main dosage forms include large-volume injections, small-volume injections, oral liquids, tablets, hard capsules, granules, syrups, ointments, tinctures, and pills. The company's main products are Si Mo Tang Oral Liquid, Shuanquan Capsule, Ginkgo Biloba Capsule and Tianma Xingnao Capsule.

Executives

Luo Yong Qing	Directors, executives
Liu Zheng Qing	Directors, executives
Liu Ling An	Director
Fu Jian Jun	Executives
Liu Na Xin	Independent director
Liu Hou Yao	Directors, Directors, and Executives
He San Xing	Directors, executives

Hunan Hansen Pharmaceutical Co Headlines

No Headlines